Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
This scoping review synthesizes randomised controlled trial evidence medicinal cannabis for treating mental health and substance use disorders. The review addresses previous limitations in study design and quality. It provides clinicians with a clearer…
Cannabinoids for Mental & Substance Use Disorders: Evidence
Current evidence on cannabinoids for substance use disorders shows limited and inconsistent benefits. Safety concerns remain a consistent finding across clinical trials. The efficacy of cannabinoids for mental and substance use disorders remains…
Cannabinoid Clinical Trials for Mental & Substance Disorders
Cannabinoid clinical trials mental disorders reveal limited evidence supporting cannabinoids as primary treatments. Current data do not establish clear efficacy or safety profiles. Clinicians should interpret patient interest with caution until stronger…
Endocannabinoid System Research: Cannabis for PTSD & SUDs
Endocannabinoid system research cannabis PTSD meta-analysis reveals trauma-focused treatments remain effective for individuals using cannabis. People with PTSD and co-occurring substance use disorders show comparable outcomes regardless of cannabis use.…
Cannabinoid Clinical Trials for Mental Health: Key Findings
Cannabinoid clinical trials mental health evidence remains limited and inconclusive. Current research does not establish clear efficacy or safety profiles for cannabinoids in mental health treatment. Clinicians should interpret approvals cautiously given…
The efficacy and safety of cannabinoids for mental and substance use disorders
This review examines cannabinoids for mental substance use disorders evidence, focusing on their efficacy and safety. Mental health and substance use disorders are common reasons for cannabinoid use. The study highlights the need for careful clinical…
Research Digest: 40 Recent Cannabis Clinical Studies – March 20, 2026
This research digest cannabis clinical studies March 2026 compiles 40 recent peer-reviewed studies curated for clinical relevance and evidence quality. It highlights key findings from cannabis clinical research and evidence reviews. Stay informed with…
Cannabinoid Clinical Trials: PTSD and Substance Use
Cannabinoid clinical trials PTSD substance use reveal that cannabis does not reduce the effectiveness of trauma-focused treatments. People with PTSD and substance use disorders benefit from evidence-based therapies despite cannabis use. These trials…
Outcomes of Cannabis Use in Trauma-Focused PTSD and SUD Treatment
Cannabis use trauma-focused treatment PTSD SUD outcomes reveal that cannabis use does not undermine the effectiveness of trauma-focused PTSD interventions. Patients with PTSD and substance use disorders benefit from these evidence-based treatments even…
Cannabinoids for Mental, Substance Use Disorders ‘Rarely Justified,’ Study Suggests
This article reviews cannabinoid clinical trials mental disorders evidence indicating limited efficacy for mental health and substance use disorders. The findings suggest cannabinoids offer minimal benefit for cannabis withdrawal and no advantage over…